Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.31%
#2 aelf aelf +23.02%
#3 Venom Venom +19.12%
#4 Bitway Bitway +13.51%
#5 Pons Pons +10.65%
#6 Decred Decred +10.50%
#7 TRIA TRIA +9.00%
#8 MarsCoin MarsCoin +8.85%
#9 Wibx Wibx +8.12%
#10 AtomOne AtomOne +7.71%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
設定
言語
日本
通貨
USD
テーマ
Aelis Farma S.A. Aelis Farma S.A.

Aelis Farma S.A.

AELIS
株式のランク #30387
Aelis Farma S.A., a French biotechnology company founded in 2013 and... Aelis Farma S.A., a French biotechnology company founded in 2013 and headquartered in Bordeaux, is dedicated to the discovery and development of treatments for brain-related illnesses. The firm's research pipeline primarily focuses on signaling-specific inhibitors that target CB1 receptors. Its leading investigational drug, AEF0117, is currently advancing through Phase 2b clinical trials, designed to alleviate the harmful impacts of excessive cannabis consumption. Furthermore, AEF0217, another key drug candidate, has successfully completed Phase 1 clinical trials, with the goal of addressing cognitive impairments linked to Down syndrome and other similar conditions.
株価
$1.25
最終同期: 2026-08-18
時価総額
$17.05M
変化（1日）
-1.50%
変化（1年）
-22.24%
国
FR
取引 Aelis Farma S.A. (AELIS)

カテゴリー

Healthcare
Aelis Farma S.A.（AELIS）の株式分割履歴
Aelis Farma S.A.株（シンボル：AELIS）は合計で0回の株式分割を実施しました。
最新の株式分割はAug 19, 2026に行われました。
Aug 19, 2026より前に購入されたAELIS株は、現在0AELIS株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE